Search
Applied DNA Sciences Inc
APDNAdd to Watchlist
5.620USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
2.59MMarket Cap
LossP/E TTM
More Details of Applied DNA Sciences Inc Company
Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
Applied DNA Sciences Inc Info
Ticker SymbolAPDN
Company nameBNB Plus Corp
IPO dateAug 24, 2001
CEOShorrock (Clay)
Number of employees46
Security typeOrdinary Share
Fiscal year-endAug 24
Address50 Health Sciences Drive
CitySTONY BROOK
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code11790
Phone16312408800
Websitehttps://adnas.com/
Ticker SymbolAPDN
IPO dateAug 24, 2001
CEOShorrock (Clay)
Company Executives of Applied DNA Sciences Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Joshua (Josh) Kruger
Mr. Joshua (Josh) Kruger
Chairman of the Board
Chairman of the Board
150.60K
+50.00%
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
75.30K
+75.17%
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
22.52K
+0.01%
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
22.51K
--
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
22.51K
-0.00%
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
Chief Executive Officer
Chief Executive Officer
12.62K
-48.20%
Ms. Beth M. Jantzen
Ms. Beth M. Jantzen
Chief Financial Officer
Chief Financial Officer
10.21K
-83.06%
Ms. Elizabeth M. Schmalz Shaheen
Ms. Elizabeth M. Schmalz Shaheen
Independent Director
Independent Director
--
--
Mr. Sanjay M. Hurry
Mr. Sanjay M. Hurry
Executive Director - Investor Relations and Corporate Communications
Executive Director - Investor Relations and Corporate Communications
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Joshua (Josh) Kruger
Mr. Joshua (Josh) Kruger
Chairman of the Board
Chairman of the Board
150.60K
+50.00%
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
75.30K
+75.17%
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
22.52K
+0.01%
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
22.51K
--
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
22.51K
-0.00%
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
Chief Executive Officer
Chief Executive Officer
12.62K
-48.20%
FAQs
Who are the top five shareholders of Applied DNA Sciences Inc?
The top five shareholders of Applied DNA Sciences Inc are: Mr. Joshua (Josh) Kruger
How many institutions hold shares of Applied DNA Sciences Inc (APDN)?
As of 2026Q1, 63 institutions hold shares of Applied DNA Sciences Inc, with a combined market value of approximately 115.59K, accounting for 2.04% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 21093.00.
What is the biggest source of revenue for Applied DNA Sciences Inc?
In 2026Q1, the Product and authentication services - Large scale DNA production business generated the highest revenue for Applied DNA Sciences Inc, amounting to 423.01K and accounting for 74.82% of total revenue.